Literature DB >> 14714122

German research network on schizophrenia-bridging the gap between research and care.

Wolfgang Wölwer1, Gerhard Buchkremer, Heinz Häfner, Joachim Klosterkötter, Wolfgang Maier, Hans-Jürgen Möller, Wolfgang Gaebel.   

Abstract

The German Research Network on Schizophrenia (GRNS) is a nationwide network of presently 16 psychiatric university departments, 14 state and district hospitals, as well as six local networks of psychiatric practices and general practitioners, which are collaborating in about 25 interrelated, multicentre projects on schizophrenia research. The GRNS aims to intensify collaboration and knowledge exchange between leading research institutions and qualified routine care facilities, both within (horizontal network) and between (vertical network) the two levels of research and care, in order to create the scientific preconditions for optimization of care in patients with schizophrenia. With respect to illness development, the network is organized into two main "Project Networks" (PN). Whereas PN I targets the implementation of early detection and early intervention strategies, PN II aims at optimization of acute and long-term treatment, especially in first-episode patients. PN II also includes projects aiming at improvement of rehabilitation, particularly in patients with residual symptoms. Furthermore, there is a "Special Network" on molecular and pharmaco-genetics. Several more general projects address fighting stigma and discrimination, health care economy, continuing medical education, quality assurance, and methodology. The network is mainly funded by the German Ministry for Research spanning a period of 5 years.

Entities:  

Mesh:

Year:  2003        PMID: 14714122     DOI: 10.1007/s00406-003-0468-8

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  11 in total

1.  Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methods.

Authors:  Rebecca Schennach; Hans-Jürgen Möller; Michael Obermeier; Florian Seemüller; Markus Jäger; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Richard Musil; Ilja Spellmann; Michael Riedel
Journal:  Int J Methods Psychiatr Res       Date:  2015-07-14       Impact factor: 4.035

2.  What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial.

Authors:  Rebecca Schennach; Michael Riedel; Michael Obermeier; Ilja Spellmann; Richard Musil; Markus Jäger; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-27       Impact factor: 5.270

3.  [Guidelines based on decision support software. Quality management in neurological outpatient schizophrenia treatment].

Authors:  B Janssen; R Menke; F Pourhassan; D Gessner-Ozokyay; R Peters; W Gaebel
Journal:  Nervenarzt       Date:  2006-05       Impact factor: 1.214

4.  [A telephone hotline as an easily accessible service for questions on schizophrenia].

Authors:  A Wessling; W Wölwer; S Heres; M Mayenberger; C Rummel; M Sievers; M Wagner; J Klosterkötter; W Gaebel
Journal:  Nervenarzt       Date:  2006-09       Impact factor: 1.214

5.  Neuropsychological impairments predict the clinical course in schizophrenia.

Authors:  Wolfgang Wölwer; Jürgen Brinkmeyer; Mathias Riesbeck; Lena Freimüller; Ansgar Klimke; Michael Wagner; Hans-Jürgen Möller; Stefan Klingberg; Wolfgang Gaebel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

6.  Prevention of rehospitalization in schizophrenia: results of an integrated care project in Germany.

Authors:  Christian Schmidt-Kraepelin; Birgit Janssen; Wolfgang Gaebel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

Review 7.  Kraepelin and psychotic prodromal conditions.

Authors:  Joachim Klosterkötter; Frauke Schultze-Lutter; Stephan Ruhrmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

8.  [Changes in the public's social distance toward individuals with schizophrenia in six German cities. Results of representative pre- and postinterventional telephone surveys from 2001 to 2004].

Authors:  A Baumann; H Zäske; P Decker; J Klosterkötter; W Maier; H J Möller; W Gaebel
Journal:  Nervenarzt       Date:  2007-07       Impact factor: 1.214

Review 9.  The German Research Network on Schizophrenia--impact on the management of schizophrenia.

Authors:  Wolfgang Wölwer; Anja Baumann; Andreas Bechdolf; Gerhard Buchkremer; Heinz Häfner; Birgit Janssen; Joachim Klosterkötter; Wolfgang Maier; Hans-Jürgen Möller; Stephan Ruhrmann; Wolfgang Gaebel
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

10.  Internal capsule size associated with outcome in first-episode schizophrenia.

Authors:  Thomas Wobrock; Oliver Gruber; Thomas Schneider-Axmann; Wolfgang Wölwer; Wolfgang Gaebel; Mathias Riesbeck; Wolfgang Maier; Joachim Klosterkötter; Frank Schneider; Gerd Buchkremer; Hans-Jürgen Möller; Andrea Schmitt; Stefan Bender; Ralf Schlösser; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-02-17       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.